Sigma Healthcare Ltd ( (AU:SIG) ) has issued an announcement.
Sigma Healthcare Ltd has announced the appointment of Damien Gance as a director, effective from February 12, 2025. The announcement detailed Gance’s significant indirect interests in the company through various trusts and entities, totaling over 400 million ordinary shares, indicating a substantial stake that could influence the company’s strategic direction and decisions.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd is a company operating in the healthcare industry, primarily focusing on the distribution and retail of pharmaceutical products and services. It serves a broad market, including pharmacies and healthcare providers, with a strong presence in the Australian healthcare sector.
YTD Price Performance: 6.37%
Average Trading Volume: 7,634
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €2.69B
See more data about SIG stock on TipRanks’ Stock Analysis page.